All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR REVENUES

EBITDA (2022)

77,2 (18,7% of turnover)

EBIT (2022)

51,7 (12,5% of turnover)

NET RESULT (2022)

37,8 (9,2% of turnover)

RELATED PAPERS

Find out more

OUR FIGURES BY FOCUS AREA (€ Millions, 2022)

Net revenue

411,1

€ Millions

153,9 € Millions

JOINT CARE

82,2 € Millions

EYE CARE

47,5 € Millions

SKIN CARE

34,3 € Millions

CORTICOSTEROIDS

4,1 € Millions

ACTIVE SUBSTANCES

89,0 € Millions

OTHER

OUR FIGURES BY PRODUCT CATEGORY (2022)

PRESCRIPTION DRUGS

MEDICAL DEVICES

VACCINES

OTHER

OUR FIGURES BY GEOGRAPHICAL AREA (€ Millions, 2022)

Net revenue

412,1

€ Millions

216,2 € Millions

ITALY

112,7 € Millions

EUROPE

58,4 € Millions

USA

15,8 € Millions

MENA

9,0 € Millions

RoW

OUR GROUP

GOVERNANCE

Find out more